~~<i id='40573E1B4C'><strike id='40573E1B4C'><tt id='40573E1B4C'><pre id='40573E1B4C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：hotspot 2025-09-30 19:26:01 - browse：28

It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Families look for replacement for GSK asthma drug Flovent

focus

Wikipedia

explore

hotspot

1:10Asthetemperatureclimbs,sodoesthedangerforchildrenleftinhotvehicles.STOCKPHOTO/GettyImagesAFlorid

WSS

Microsoft's Peter Lee: Generative AI could help doctors be more human

'The View' co

Microsoft's Peter Lee: Generative AI could help doctors be more human

Why Talkspace is targeting Medicare, a tricky market

New chart reveals military’s vast involvement in Operation Warp Speed

Readout Newsletter: BridgeBio, Akero, and human embryo models

focus

comprehensive

focus

Hepatitis C has a cure — but many Americans still lack access to it

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Hepatitis C has a cure — but many Americans still lack access to it

Longer MASH drug regimen improved liver, Akero study finds

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Florida health officials providing scant details on measles cases

Novavax promises a turnaround & Lilly roils the obesity market

Lack of health data on LGBTQ+ people has serious consequences

Medicare proposal to cover medical devices draws a mixed reaction

Medicare drug price negotiation hearing pits pharma v Biden admin

Wikipedia

A new approach to psychiatric drug development

Ozempic has benefits for kidney disease as well as diabetes

Why the advice to take all your antibiotics may be wrong

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Longer MASH drug regimen improved liver, Akero study finds

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

explore

explore

hotspot

hotspot